J-Lex

Cybainco Tablets 50mg

Cybainco Tablets 50mg (also known as Cibinqo), manufactured by Pfizer, contain abrocitinib (YJ code: 4490037F1026). This Janus kinase 1 (JAK1) inhibitor is used to treat adults and pediatric patients 12 years and older with moderate-to-severe atopic dermatitis, with a recommended dose of 50mg per tablet.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer